Cook Group said today that it completed the sale of Cook Pharmica to Catalent (NYSE:CTLT).
Catalent announced last month that it planned to dish out $950 million to buy the biologics contract manufacturer. The newly-acquired company will be called Catalent Bloomington, according to Cook Group.
Get the full story at our sister site, Drug Delivery Business News.